Polyvalent Immunoglobulin in COVID-19 Related ARds

NCT04350580 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome
COVID-19

Interventions

DRUG: Human immunoglobulin
DRUG: Placebo

Sponsor

Centre Hospitalier St Anne

Collaborators

[object Object]
[object Object]